Description
TriNetX is a global health research network that enables their users to collaborate, enhance trial design, accelerate patient recruitment, and bring new therapies to market faster.
TriNetX with University of Iowa Health Care provides researchers the ability to explore a limited, de-identified set of patient data. This tool is most useful for identification of patient cohorts for preparation to research.
TriNetX audiences:
- Health care organizations
- Biopharma
- Contract research organizations (CROs)
Request access
Sign in
TriNetX features
Easy to useIntuitive Design |
Predictive analyticsProjects rates at which new patients match eligibility criteria |
||
ResearcherPIs can research their own patient populations |
Self-serviceAccess to fresh patient data |
||
Real-timeScenario modeling for protocol feasibility |
SecureCompliant with international privacy regulations |
||
Personal healthAll PHI remains local |
NetworkForm collaborative networks with peer institutions and research their patient population |
||
Pre-qualifiedPre-qualified patient lists |
Industrial sponsorAttract more industry-sponsored trials |
Data available
- Demographics
- Diagnosis
- Medications
- Procedures
- Labs
- Cancer registry (NAACCR)
- Allergies
Data unavailable
- Notes
- Diagnostic reports
- DICOM image objects
- Providers
- Departments/clinics
- Patient level data
Eligibility
All UI Health Care faculty, staff, and students
University of Iowa faculty and staff involved in clinical research
Availability
Service
Monday - Friday, 7:00 a.m. - 5:00 p.m.
Application
24/7/365
Training
Overview training available upon account creation.
Video tutorials available within the interface
Service cost(s)
TriNetX is available at no cost to University of Iowa Faculty, Staff and Students
FAQ
Cite TriNetX
TriNetX is supported by the Institute for Clinical and Translational Science at the University of Iowa.
The Institute for Clinical and Translational Science at the University of Iowa is supported by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grant UM1TR004403.
The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS). This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Contact
icts-bmi-consulting@healthcare.uiowa.edu
Help the Institute for Clinical and Translational Science at the University of Iowa continue making new strides in medical research by citing the NIH CTSA program grant UM1TR004403.